<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Asif M</submitter><funding>National University of Medical Sciences</funding><pagination>8526</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12692803</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(23)</volume><pubmed_abstract>&lt;b>Background:&lt;/b> Urothelial carcinoma (UC) presents with clinically heterogeneous disease. There is an emerging need to explore the prognosis of non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Therefore, we aimed to explore the prognostic value of FGFR3 and TP53 mutations and protein expression and to investigate the diagnostic utility of urine cytology and Xpert bladder cancer monitor (BCM) assay in UC. &lt;b>Materials and Methods:&lt;/b> A prospective cross-sectional study was conducted in a cohort of 73 Pakistani patients. Cystoscopy, biopsy, tissue diagnosis, UC grade, and stage followed by immunohistochemistry (IHC) and genotyping were recorded. Voided urine samples were also collected for urine cytology and Xpert BCM. Statistical analysis was perform</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>Diagnostic and Prognostic Implications of FGFR3, TP53 Mutation and Urinary Biomarkers in Urothelial Carcinoma in Pakistani Cohort.</pubmed_title><pmcid>PMC12692803</pmcid><funding_grant_id>02/ORIC/IRF-22001</funding_grant_id><pubmed_authors>Gul A</pubmed_authors><pubmed_authors>Khadim MT</pubmed_authors><pubmed_authors>Sajid MT</pubmed_authors><pubmed_authors>Khan DA</pubmed_authors><pubmed_authors>Rashid FA</pubmed_authors><pubmed_authors>Asif M</pubmed_authors><pubmed_authors>Malik SS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic and Prognostic Implications of FGFR3, TP53 Mutation and Urinary Biomarkers in Urothelial Carcinoma in Pakistani Cohort.</name><description>&lt;b>Background:&lt;/b> Urothelial carcinoma (UC) presents with clinically heterogeneous disease. There is an emerging need to explore the prognosis of non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). Therefore, we aimed to explore the prognostic value of FGFR3 and TP53 mutations and protein expression and to investigate the diagnostic utility of urine cytology and Xpert bladder cancer monitor (BCM) assay in UC. &lt;b>Materials and Methods:&lt;/b> A prospective cross-sectional study was conducted in a cohort of 73 Pakistani patients. Cystoscopy, biopsy, tissue diagnosis, UC grade, and stage followed by immunohistochemistry (IHC) and genotyping were recorded. Voided urine samples were also collected for urine cytology and Xpert BCM. Statistical analysis was perform</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-26T14:07:20.952Z</modification><creation>2026-05-24T03:12:22.243Z</creation></dates><accession>S-EPMC12692803</accession><cross_references><pubmed>41375830</pubmed><doi>10.3390/jcm14238526</doi></cross_references></HashMap>